AbbVie
ABBV
HK$1,343
Share price
0.76%
Change (1 day)
4.41%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
EPS for AbbVie (ABBV)
EPS in 2023 (TTM): HK$28.81
According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$28.57. In 2022 the company made an earnings per share (EPS) of HK$51.68 an increase over its 2021 EPS that were of HK$50.35.
EPS history for AbbVie from 2011 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | HK$28.81 | -44.25% |
| 2022 | HK$51.68 | 2.63% |
| 2021 | HK$50.35 | 125.21% |
| 2020 | HK$22.36 | -45.69% |
| 2019 | HK$41.17 | 48.35% |
| 2018 | HK$27.75 | 7.6% |
| 2017 | HK$25.79 | -9.3% |
| 2016 | HK$28.44 | 15.48% |
| 2015 | HK$24.62 | 185.53% |
| 2014 | HK$8.62 | -57.11% |
| 2013 | HK$20.11 | -21.69% |
| 2012 | HK$25.68 | 55.73% |
| 2011 | HK$16.49 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | HK$14.44 | -49.47% | 🇺🇸 USA |
 | HK$30.82 | 7.86% | 🇺🇸 USA |
 | HK$42.14 | 47.51% | 🇺🇸 USA |
 | HK$109.83 | 284.44% | 🇺🇸 USA |
 | HK$34.08 | 19.27% | 🇺🇸 USA |
 | HK$143.29 | 401.54% | 🇺🇸 USA |
 | HK$27.17 | -4.89% | 🇬🇧 UK |
 | HK$15.41 | -46.07% | 🇬🇧 UK |
 | HK$15.21 | -46.75% | 🇺🇸 USA |